NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
This grant will invite eligible US small businesses to apply for SBIR funding from NIH, CDC, and FDA for innovative research projects, but clinical trials are not allowed and applications are not yet open.
Funder: National Institutes of Health
Due Dates (Anticipated): September 2026 (estimated full application deadline)
Funding Amounts: Not specified in the forecast; typical SBIR awards vary by phase and institute.
Summary: Supports innovative health-related research and development by eligible U.S. small businesses through the SBIR Phase I, Phase II, and Fast-Track mechanisms.
Key Information: Only U.S. small businesses (SBCs) as defined by SBA are eligible; this is a forecasted opportunity.
Description
This forecasted opportunity invites eligible U.S. small businesses to apply for Small Business Innovation Research (SBIR) grants supporting health-related research and development aligned with the missions of the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA). The program covers SBIR Phase I, Phase II, Direct to Phase II (NIH only), and Fast-Track (NIH only) applications, encouraging both individual and collaborative R&D projects that can advance biomedical and public health innovation. The Notice of Funding Opportunity (NOFO) will use the R43/R44 activity codes.
